Anti-tumor immunotherapy

Details Anti-tumor immunotherapy Anti-tumor immunotherapy

A - Human Necessities

61

K

A61K 38/45 (2006.01) A61P 35/00 (2006.01) C12N 9/12 (2006.01)

Patent

CA 2727388

The present invention relates to the use of telomerase-derived peptides for the treatment of any cancer patients, particularly for the treatment of patients with renal or prostate cancer.

La présente invention concerne lutilisation de peptides dérivés de télomérases destinés au traitement de tout patient cancéreux, en particulier le traitement de patients souffrant dun cancer rénal ou de la prostate.

Affiliated with

Also associated with

Rating

Anti-tumor immunotherapy does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Anti-tumor immunotherapy, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Anti-tumor immunotherapy will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1486286